A detailed history of Legal & General Group PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Legal & General Group PLC holds 6,986,788 shares of LLY stock, worth $5.44 Billion. This represents 1.32% of its overall portfolio holdings.

Number of Shares
6,986,788
Previous 6,986,788 -0.0%
Holding current value
$5.44 Billion
Previous $6.19 Billion -0.0%
% of portfolio
1.32%
Previous 1.32%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $99.6 Million - $124 Million
-128,997 Reduced 1.81%
6,986,788 $6.19 Billion
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $3.05 Million - $3.83 Million
4,214 Added 0.06%
7,115,785 $6.44 Billion
Q1 2024

Jul 01, 2024

BUY
$592.2 - $792.28 $34.7 Million - $46.4 Million
58,566 Added 0.83%
7,111,571 $5.53 Billion
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $47.6 Million - $63.7 Million
-80,394 Reduced 1.13%
7,053,005 $5.49 Billion
Q4 2023

Feb 15, 2024

BUY
$525.19 - $619.13 $635 Million - $748 Million
1,208,594 Added 20.4%
7,133,399 $4.16 Billion
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $79.3 Million - $109 Million
-182,455 Reduced 2.99%
5,924,805 $3.18 Billion
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $68.8 Million - $92.1 Million
196,292 Added 3.32%
6,107,260 $2.86 Billion
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $34.3 Million - $40.3 Million
110,469 Added 1.9%
5,910,968 $2.03 Billion
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $42.6 Million - $49.7 Million
-132,605 Reduced 2.24%
5,800,499 $2.12 Billion
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $91.1 Million - $104 Million
-307,204 Reduced 4.92%
5,933,104 $1.92 Billion
Q2 2022

Aug 22, 2022

SELL
$278.73 - $327.27 $15.6 Million - $18.3 Million
-56,000 Reduced 0.89%
6,240,308 $2.02 Billion
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $82.6 Million - $103 Million
351,755 Added 5.92%
6,296,308 $1.8 Billion
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $14.8 Million - $18.4 Million
-65,852 Reduced 1.1%
5,944,553 $1.64 Billion
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $30.9 Million - $38 Million
139,476 Added 2.38%
6,010,405 $1.39 Billion
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $41.8 Million - $54 Million
231,301 Added 4.1%
5,870,929 $1.35 Billion
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $20.2 Million - $26.2 Million
-123,203 Reduced 2.14%
5,639,628 $1.05 Billion
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $9.09 Million - $12 Million
69,686 Added 1.22%
5,762,831 $973 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $18.4 Million - $21.3 Million
-126,174 Reduced 2.17%
5,693,145 $843 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $2.17 Million - $2.61 Million
-15,926 Reduced 0.27%
5,819,319 $955 Million
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $21.5 Million - $26.6 Million
180,486 Added 3.19%
5,835,245 $809 Million
Q4 2019

Feb 13, 2020

BUY
$106.92 - $132.43 $8.83 Million - $10.9 Million
82,593 Added 1.48%
5,654,759 $743 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $2.32 Million - $2.52 Million
21,718 Added 0.39%
5,572,166 $623 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $7.7 Million - $8.99 Million
-69,532 Reduced 1.24%
5,550,448 $615 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $74.7 Million - $87.9 Million
671,128 Added 13.56%
5,619,980 $729 Million
Q4 2018

Feb 15, 2019

BUY
$105.9 - $118.64 $25.2 Million - $28.2 Million
237,632 Added 5.04%
4,948,852 $573 Million
Q3 2018

Nov 20, 2018

BUY
$85.86 - $107.31 $2.71 Million - $3.39 Million
31,617 Added 0.68%
4,711,220 $506 Million
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $2.73 Million - $3.14 Million
-36,105 Reduced 0.77%
4,679,603 $399 Million
Q1 2018

May 17, 2018

SELL
$74.21 - $87.6 $20.7 Million - $24.4 Million
-278,553 Reduced 5.58%
4,715,708 $365 Million
Q4 2017

Feb 13, 2018

BUY
$81.94 - $87.89 $409 Million - $439 Million
4,994,261
4,994,261 $422 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.